The FDA Amendment Act, signed by then President Bush in October 2007, contains authorization for creating Critical Path Public-Private Partnerships which support the work performed by Critical Path Institute and its collaborators.
Financial Status
Support
Critical Path Institute (C-Path) was launched in 2005 with a five-year commitment of more than $9 million in pledges from the Arizona community. Even through difficult financial times, more than 98% of these pledges have been honored. In addition, Science Foundation Arizona (SFAz) has awarded C-Path over $14 million to build upon the community's initial investment, making it possible for C-Path to create public-private partnerships that enable the biopharmaceutical industry to work closely with the U.S. Food and Drug Administration (FDA). The first legislation sponsored by Arizona Congresswoman Gabrielle Giffords created the FDA's Critical Path Public-Private Partnerships and, because of this, C-Path applied for and received a five-year award of $8.5 million. Other grants, including a recent award of $2.1 million from the Bill & Melinda Gates Foundation, are part of the return on Arizona's investment. Our promise to the community was to fundamentally change drug development, a promise that is being fulfilled.
C-Path is also expected to help grow the number of high-paying jobs in Arizona's biosciences sector. Fully 98.5% of all revenues go to support our people and programs. C-Path has competed successfully for a number of multimillion-dollar federal and foundation grants. Critical Path Institute opened its doors with five employees and ended FY'11 with 55 employees. In addition, C-Path and its team of scientists have helped launch four new biotechnology companies in Arizona.
The steadfast support of the community, the passion and dedication of our scientists and staff, and the trust of our stakeholders have enabled C-Path to become an internationally respected global organization that is fulfilling its mission of improving health and saving lives.